Expore JDRF

Ask Your Senators to Sign Letter Regarding Artificial Pancreas Systems

Add Your Name

{{takeActionQuestions[key].legend}} * (Optional)
You are not able to take part in this effort, due to your location.
By clicking "Send Your Message" you are agreeing to our terms of service, including our use of cookies.

Recipients

  • Targeted recipients based on your address
person

(D) - (R) - (I) - ,

Please Sign Diabetes Caucus Letter to CMS Regarding Artificial Pancreas Systems

Dear [Decision Maker],

As your constituent and an advocate for JDRF, I urge you to support access to diabetes technologies for the type 1 diabetes (T1D) community. Please join other Members of Congress in signing the Diabetes Caucus letter that requests the Centers for Medicare & Medicaid Services (CMS) to work with the key stakeholders in the T1D community to ensure that Medicare beneficiaries have access to the next generation of diabetes management technologies, including artificial pancreas (AP) systems.

AP systems connect two devices - a continuous glucose monitor (CGM), and an insulin pump. These innovative devices provide real-time feedback on glucose levels and use that information to adjust insulin dosing. AP systems help people with T1D manage the disease and avoid complications that lead to higher healthcare costs.

Other Federal health agencies and Congress have made developing and approving these systems a priority. Also, 25 of the nation's largest private plans recognize the importance of innovative diabetes technologies and cover the first generation of AP systems. CMS has made strides by providing coverage for certain CGMs and insulin pumps. The time is now for the agency to focus on ensuring access for the next generation of innovative diabetes technologies.

Thank you for listening to my concerns and supporting access to innovative diabetes technologies that help improve diabetes care.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
,
By clicking "Send Your Message" you are agreeing to our terms of service, including our use of cookies.